Survival analysis of 306 European Spanish patients with systemic lupus erythematosus

被引:57
|
作者
Blanco, FJ
Gomez-Reino, JJ
de la Mata, J
Corrales, A
Rodriguez-Valverde, V
Rosas, JC
de la Camara, AG
Pascual, E
机构
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
[2] Hosp Marques Valdecilla, Santander, Spain
[3] Hosp Gen Alicante, Alicante, Spain
关键词
systemic lupus erythematosus; survival in lupus; predictors of mortality; causes of death; Caucasian south European lupus;
D O I
10.1191/096120398678919930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe survival of lupus in South European Spanish patients. Patients and Methods: Observational study of all SLE Spanish patients seen at three University Hospitals between 1975 and 1993. The charts of all patients were retrospectively reviewed. Sixty-four clinic and laboratory variables were extracted from charts. Univariate analysis, multivariate Cox proportional hazard regression analysis, actuarial life tables and multiple logistic regression analysis were used to calculate survival probability and identify variables associated with survival. Results: Three hundred and six (275 female and 31 male) patients were identified. Their mean age at diagnosis was 31.9 years (range 4 to 85). The mean duration of followup was 79 (1-126) months. Thirty-one patients died. The most common cause of death was infection (29%). Five, 10 and 15 years' survival rate was 90% +/- 0.0158, 85% +/- 0.0262 and 80% +/- 0.0413, respectively. Log-rank analysis showed that male sex, proteinuria and nephropathy at diagnosis were associated with poor survival. By univariate and multivariate analysis male gender, nephropathy and CNS involvement were associated with worse survival. Conclusion: In SLE patients from Spain, rate of survival is similar to other Caucasian patients, and better than other ethnic groups of Spanish ancestry. Other factors rather than genetic factors could explain our findings.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [21] Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
    Laino, Maria
    Enguita, Monica
    Loricera, Javier
    Moriano Morales, Clara
    Lasa, Carmen
    Calvo Rio, Vanesa
    Narvaez, Javier
    Navarro Guerra, Pablo Ignacio
    Casafont-Sole, Ivette
    Font Urgelles, Judit
    Gallego, Adela
    Carrion-Barbera, Irene
    Quiroga, Patricia
    Castaneda, Santos
    Garcia-Aparicio, Angel
    Belzunegui Otano, Joaquin Maria
    Ramon De Dios, Juan
    Lopez, Marta
    Hernandez, Samuel
    Heredia Martin, Sergi
    Farinas, Aaron
    Navarro, Francisco
    Juan Fragio, Jorge
    Escudero, Carmen
    Ortega Castro, Rafaela
    del Olmo Perez, Leticia
    Pinillos, Valvanera
    Labrador, Eztizen
    Ortega, Mamen
    Castro Perez, Patricia
    Blanco-Madrigal, Juan Maria
    Paulino, Marcos
    Angeles Matias, Maria
    Calvo-Aranda, Enrique
    Peralta, Cilia
    Garcia, Silvia
    Camins-Fabregas, Jordi
    Garijo Bufort, Marta
    Fabregas, Dolores
    Urruticoechea, Ana
    Medina Malone, Miguel
    Cossio Jimenez, Piter Jose
    Perez-Pampin, Eva
    Varas de Dios, Blanca
    Vazquez Galeano, Carlos
    Vegas Revenga, Nuria
    Rusinovich, Olga
    Giner-Serret, Emilio
    Ramon Lamua, Jose
    Aldasoro, Vicente
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4639 - 4643
  • [22] Lupus Nephritis of the Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
    Laino, Maria
    Enguita, Monica
    Navarro, Pablo
    Loricera, Javier
    Garcia-Aparicio, Angel
    Lasa, Carmen
    Calvo Rio, Vanesa
    Gallego, Adela
    Moriano Morales, Clara
    Narvaez, Javier
    Carrion Barbera, Maria Irene
    Camins-Fabregas, Jordi
    Belzunegui Otano, Joaquin Maria
    Urruticoechea, Ana
    del Olmo Perez, Leticia
    Castaneda, Santos
    Quiroga, Patricia
    Casafont-Sole, Ivette
    Jimenez De Aber, Juan Ramon De Dios
    Lopez, Marta
    Font Urgelles, Judit
    Ortega Castro, Rafaela
    Garijo Bufort, Marta
    Juan Fragio, Jorge
    Vazquez, Ignacio
    Ortega, Mamen
    Farinas, Aaron
    Peralta, Cilia
    Maria Blanco, Juan
    Heredia Martin, Sergi
    Valvanera Pinillos, Maria
    Labrador-Sanchez, Eztizen
    Cossio Jimenez, Piter Jose
    Vazquez Galeano, Carlos
    Aldasoro, Vicente
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1174 - 1177
  • [23] Mortality and Survival in Systemic Lupus Erythematosus Patients: Trends in a Spanish Cohort from 1985 to 2013.
    Heredia, Sergi
    Narvaez, Javier
    Zacarias, Andrea
    Ricse, Milagros
    Albert, Gloria
    Armengol, Eulalia
    Borrell, Helena
    Capdevila, Olga
    Mitjavila, Francesca
    Rozadilla, Toni
    Juanola, Xavier
    Miquel Nolla, Joan
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1146 - S1146
  • [24] Predictors of survival in systemic lupus erythematosus
    Kasitanon, Nuntana
    Magder, Laurence S.
    Petri, Michelle
    MEDICINE, 2006, 85 (03) : 147 - 156
  • [25] POLYAUTOIMMUNITY IN SYSTEMIC LUPUS ERYTHEMATOSUS. DATA FROM A LARGE SPANISH COHORT: SPANISH SOCIETY OF RHEUMATOLOGY REGISTRY OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (RELESSER).
    Mena-Vazquez, Natalia
    Fernandez-Nebro, Antonio
    Rua-Figueroa, Inigo
    Galindo-Izquierdo, Maria
    Ovalles, Juan
    Olive, Alejandro
    Calvo, Jaime
    Menor-Almagro, Raul
    Tomero Muriel, Eva
    Uriarte Isacelaya, Esther
    Boteanu, Alina
    Andres, Mariano
    Freire Gonzalez, Mercedes
    Narvaez, J.
    Vazquez Rodriguez, Tomas
    Blanco, Ricardo
    Hernandez Beriain, Jose A.
    Ibanez, Jesus
    Raya, Enrique
    Calvet, Joan
    Pego-Reigosa, Jose M.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1174 - 1174
  • [26] SURVIVAL IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    RIDLEY, MG
    LONG, PJ
    HUGHES, GRV
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 1988, 39 (03): : 237 - 241
  • [27] Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
    Ruiz-Irastorza, G.
    Egurbide, M-V
    Pijoan, J-I
    Garmendia, M.
    Villar, I.
    Martinez-Berriotxoa, A.
    Erdozain, J-G
    Aguirre, C.
    LUPUS, 2006, 15 (09) : 577 - 583
  • [28] SURVIVAL AND CAUSES OF DEATH IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    HALBERG, P
    CLINICAL RHEUMATOLOGY, 1991, 10 (04) : 367 - 368
  • [29] What to do to improve the survival of patients with systemic lupus erythematosus?
    Font, Josep
    Cervera, Ricard
    MEDICINA CLINICA, 2007, 128 (03): : 95 - 96
  • [30] Survival and cause of death in patients with systemic lupus erythematosus.
    Gonzàlez-Montagut, C
    López-Longo, FJ
    Montoro, M
    Vázquez-Coleman, J
    Nuño, L
    Ortega, C
    González, CM
    Monteagudo, I
    Carreño, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S186 - S186